Timothy Cooke

Timothy Cooke has a wealth of experience in the biotechnology and pharmaceutical industries. Timothy is currently serving as the Chief Executive Officer at Omniose, a biotechnology company specializing in developing polysaccharide conjugate vaccines. Prior to this, Cooke held the position of Senior Vice President, Commercial Business at Ology Bioservices, where they oversaw the development of live virus product candidates for infectious disease vaccines and gene therapy. Timothy also served as the Chief Executive Officer at NovaDigm Therapeutics, focusing on the development of vaccines and immunotherapeutics for fungal and bacterial infections. Cooke has held executive roles at AVANT Immunotherapeutics and Mojave Therapeutics, leading the development of various vaccines and biopharmaceuticals. Earlier in their career, they worked at Merck in the Vaccine Division, where they played a key role in their vaccine product portfolio. Throughout their career, Cooke has demonstrated a track record of successful leadership and strategic decision-making in the field of biotechnology and pharmaceuticals.

Timothy Cooke has a Bachelor of Science degree in Chemistry from Saint Joseph's University. Timothy has also attended Columbia University Graduate School of Arts and Sciences, where they pursued a Ph.D. in Bio-Organic Chemistry. In addition, they have pursued an MBA with a focus on Marketing from Columbia Business School. The specific start and end dates for each of these educational experiences are not provided.